Research Suggests the Thymus is Critical in Immunotherapy Outcomes
Cancer patients with healthier thymus glands show dramatically better responses to immunotherapy, cutting progression risks by roughly one-third and death risks by nearly half compared to those with weaker thymic function. New research leveraging artificial intelligence to evaluate chest scans challenges medical assumptions that dismissed this immune organ as irrelevant past childhood, revealing it may determine who benefits from modern cancer treatments that are dependent on robust immune systems. Separate research tracking over 27,000 adults found those with stronger thymic function lived longer while experiencing half the premature mortality, one-third fewer cardiovascular deaths, and substantially reduced lung cancer development versus people showing poorer thymic health on imaging. Hugo Aerts from Harvard Medical School and Dana-Farber Cancer Institute,…
